Intravascular ultrasound, angioscopic and histopathological characterisation of heterogeneous patterns of restenosis after sirolimus-eluting stent implantation: Insights into potential "thromborestenosis" phenomenon

EuroIntervention

Volumn 6, Issue 3, 2010, Pages 380-387

  Oikawa, Yuji ^a   Yajima, Junji ^a   Costa, Marco A ^b   Matsuno, Shunsuke ^a   Akabane, Masafumi ^a   Funada, Ryuichi ^a   Inaba, Toshiro ^a   Nakagawa, Yuya ^a   Nakamura, Michinari ^a   Nagashima, Kazuyuki ^a   Kirigaya, Hajime ^a   Ogasawara, Ken ^a   Sawada, Hitoshi ^a   Aizawa, Tadanori ^a  

^a THE CARDIOVASCULAR INSTITUTE   (Japan)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Atherectomy; Bare metal stent; Sirolimus eluting stent

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; COLLAGEN; FIBRIN; RAPAMYCIN; TICLOPIDINE; IMMUNOSUPPRESSIVE AGENT;

ADULT; AGED; ANGIOSCOPY; ARTICLE; BARE METAL STENT; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ANGIOSCOPY; DIRECTIONAL ATHERECTOMY; DISEASE ASSOCIATION; DRUG ELUTING STENT; FEMALE; FIBRIN DEPOSITION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IN-STENT RESTENOSIS; INFLAMMATORY INFILTRATE; INTERMETHOD COMPARISON; INTRAVASCULAR ULTRASOUND; MALE; STENT THROMBOSIS; TISSUE SECTION; COMPARATIVE STUDY; CORONARY ARTERY THROMBOSIS; CORONARY BLOOD VESSEL; DIFFERENTIAL DIAGNOSIS; ECHOGRAPHY; ENDOSCOPIC ECHOGRAPHY; FOLLOW UP; METHODOLOGY; MIDDLE AGED; PATHOLOGY; REPRODUCIBILITY; RESTENOSIS;

AGED; AGED, 80 AND OVER; ANGIOSCOPY; CORONARY RESTENOSIS; CORONARY THROMBOSIS; CORONARY VESSELS; DIAGNOSIS, DIFFERENTIAL; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SIROLIMUS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 79952778553     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV6I3A63     Document Type: Article

References (24)

1. Marx SO, Marks AR. Bench to bedside: the development of rapamycin and its application to stent restenosis. Circulation. 2001;104:852-855. (Pubitemid 32778031)
2. Suzuki T, Kopia G, Hayashi S, Bailey LR, Llanos G, Wilensky R, Klugherz BD, Papandreou G, Narayan P, Leon MB, Yeung AC, Tio F, Tsao PS, Falotico R, Carter AJ. Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model. Circulation. 2001;104:1188-1193. (Pubitemid 32830406)
3. Sousa JE, Costa MA, Abizaid A, Abizaid AS, Feres F, Pinto IM, Seixas AC, Staico R, Mattos LA, Sousa AG, Falotico R, Jaeger J, Popma JJ, Serruys PW. Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation. 2001;103:192-195. (Pubitemid 32095401)
4. Rensing BJ, Vos J, Smits PC, Foley DP, van den Brand MJ, van der Giessen WJ, de Feijter PJ, Serruys PW. Coronary restenosis elimination with a sirolimus eluting stent: first European human experience with 6-month angiographic and intravascular ultrasonic follow-up. Eur Heart J. 2001;22:2125-2130. (Pubitemid 33091454)
5. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnar F, Falotico R. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002;346:1773-1780. (Pubitemid 34586912)
6. Serruys PW, Degertekin M, Tanabe K, Abizaid A, Sousa JE, Colombo A, Guagliumi G, Wijns W, Lindeboom WK, Ligthart J, de Feyter PJ, Morice MC. Intravascular ultrasound findings in the multi-center, randomized, double-blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) trial. Circulation. 2002;106:798-803.
7. Degertekin M, Lemos PA, Lee CH, Tanabe K, Sousa JE, Abizaid A, Regar E, Sianos G, van der Giessen WJ, de Feyter PJ, Wuelfert E, Popma JJ, Serruys PW. Intravascular ultrasound evaluation after sirolimus eluting stent implantation for de novo and in-stent restenosis lesions. Eur Heart J. 2004;25:32-38. (Pubitemid 38055590)
8. Sousa JE, Costa MA, Abizaid A, Feres F, Seixas AC, Tanajura LF, Mattos LA, Falotico R, Jaeger J, Popma JJ, Serruys PW, Sousa AG. Fouryear angiographic and intravascular ultrasound follow-up of patients treated with sirolimus-eluting stents. Circulation. 2005;111:2326-2329. (Pubitemid 40647068)
9. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, Kutys R, Skorija K, Gold HK, Virmani R. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol. 2006;48:193-202. (Pubitemid 43929240)
10. Farb A, Sangiorgi G, Carter AJ, Walley VM, Edwards WD, Schwartz RS, Virmani R. Pathology of acute and chronic coronary stenting in humans. Circulation. 1999;99:44-52. (Pubitemid 29035956)
11. Virmani R, Kolodgie FD, Farb A, Lafont A. Drug eluting stents: are human and animal studies comparable? Heart. 2003;89:133-138.
12. van Beusekom HM, Saia F, Zindler JD, Lemos PA, Swager-Ten Hoor SL, van Leeuwen MA, de Feijter PJ, Serruys PW, van der Giessen WJ. Drug-eluting stents show delayed healing: paclitaxel more pronounced than sirolimus. Eur Heart J. 2007;28:974-979. (Pubitemid 47343915)
13. Guagliumi G, Farb A, Musumeci G, Valsecchi O, Tespili M, Motta T, Virmani R. Images in cardiovascular medicine. Sirolimus-eluting stent implanted in human coronary artery for 16 months: pathological findings. Circulation. 2003;107:1340-1341.
14. Sousa JE, Costa MA, Farb A, Abizaid A, Sousa A, Seixas AC, da Silva LM, Feres F, Pinto I, Mattos LA, Virmani R. Images in cardiovascular medicine. Vascular healing 4 years after the implantation of sirolimus-eluting stent in humans: a histopathological examination. Circulation. 2004;110:e5-6.
15. McFadden EP, Stabile E, Regar E, Cheneau E, Ong AT, Kinnaird T, Suddath WO, Weissman NJ, Torguson R, Kent KM, Pichard AD, Satler LF, Waksman R, Serruys PW. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet. 2004;364:1519-1521. (Pubitemid 39410418)
16. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, Airoldi F, Chieffo A, Montorfano M, Carlino M, Michev I, Corvaja N, Briguori C, Gerckens U, Grube E, Colombo A. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. Jama. 2005;293:2126-2130. (Pubitemid 40617065)
17. Fujii K, Mintz GS, Kobayashi Y, Carlier SG, Takebayashi H, Yasuda T, Moussa I, Dangas G, Mehran R, Lansky AJ, Reyes A, Kreps E, Collins M, Colombo A, Stone GW, Teirstein PS, Leon MB, Moses JW. Contribution of stent underexpansion to recurrence after sirolimus-eluting stent implantation for in-stent restenosis. Circulation. 2004;109:1085-1088. (Pubitemid 38332610)
18. Sonoda S, Morino Y, Ako J, Terashima M, Hassan AH, Bonneau HN, Leon MB, Moses JW, Yock PG, Honda Y, Kuntz RE, Fitzgerald PJ. Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation: serial intravascular ultrasound analysis from the sirius trial. J Am Coll Cardiol. 2004;43:1959-1963. (Pubitemid 38686788)
19. Takebayashi H, Mintz GS, Carlier SG, Kobayashi Y, Fujii K, Yasuda T, Costa RA, Moussa I, Dangas GD, Mehran R, Lansky AJ, Kreps E, Collins MB, Colombo A, Stone GW, Leon MB, Moses JW. Nonuniform strut distribution correlates with more neointimal hyperplasia after sirolimus-eluting stent implantation. Circulation. 2004;110:3430-3434. (Pubitemid 39602221)
20. Costa MA, Sabate M, Angiolillo DJ, Jimenez-Quevedo P, Teirstein P, Carter A, Leon MB, Moses J, Zenni M, Yakubov S, Guzman LA, Gilmore P, Macaya C, Bass TA. Intravascular ultrasound characterization of the "black hole" phenomenon after drug-eluting stent implantation. Am J Cardiol. 2006;97:203-206.
21. Costa Jde R, Jr., Mintz GS, Carlier SG, Fujii K, Sano K, Kimura M, Tanaka K, Lui J, Moses JW, Leon MB. Frequency and determinants of black holes in sirolimus-eluting stent restenosis. J Invasive Cardiol. 2006;18:348-352. (Pubitemid 44182961)
22. Takano M, Ohba T, Inami S, Seimiya K, Sakai S, Mizuno K. Angioscopic differences in neointimal coverage and in persistence of thrombus between sirolimus-eluting stents and bare metal stents after a 6-month implantation. Eur Heart J. 2006;27:2189-2195. (Pubitemid 44412833)
23. Awata M, Kotani J, Uematsu M, Morozumi T, Watanabe T, Onishi T, Iida O, Sera F, Nanto S, Hori M, Nagata S. Serial angioscopic evidence of incomplete neointimal coverage after sirolimus-eluting stent implantation: comparison with bare-metal stents. Circulation. 2007;116:910-916. (Pubitemid 47300915)
24. Kay IP, Ligthart JM, Virmani R, van Beusekom HM, Kozuma K, Carter AJ, Sianos G, van der Giessen WJ, Wardeh AJ, de Feyter PJ, Serruys PW. The black hole: echolucent tissue observed following intracoronary radiation. Int J Cardiovasc Intervent. 2003;5:137-142. (Pubitemid 37127998)